MFS
ADMS

Mirabella Financial Services’s Adamas Pharmaceuticals ADMS Stock Holding History

Mirabella Financial Services’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,628
Closed -$77K – 532
2020
Q3 		$77K Buy
+18,628
New +$72.1K 0.01% 348

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Mirabella Financial Services's ADMS Position: Q4 2020 in Review

Mirabella Financial Services sold out of Adamas Pharmaceuticals (ADMS) in Q4 2020, closing a stake of 18,628 shares — an estimated $77K sold.

Mirabella Financial Services first reported a position in ADMS in Q3 2020 and held it in 1 quarter. The position peaked at $77K in Q3 2020. 65 funds tracked by Wall St. Rank hold ADMS as of Q4 2020.

  • Mirabella Financial Services reported no remaining Adamas Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 18,628 Adamas Pharmaceuticals shares in Q4 2020, an estimated $77K.
  • Mirabella Financial Services first reported a position in Adamas Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Adamas Pharmaceuticals position peaked at $77K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.